Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Figures and Graphics
Rupp H et al.  
Saving Lives Post-MI: Highly Purified Omega-3 PUFAs for the Prevention of Sudden Death

Journal of Clinical and Basic Cardiology 2002; 5 (3): 209-214

PDF    Summary    Figures   


Figure
 
GISSI-P - Endpunkte
Figure 2: Nested endpoints classification used in GISSI-Prevenzione. All endpoints were confirmed by a blinded Endpoint Validation Committee. CVD = cardiovascular (CV) death (any CV cause); CD = cardiac death (any cardiac cause); CHD = coronary death (any coronary cause); data from [8]


Keywords: EndpointEndpunktGISSI-P studyGISSI-P-StudieSchema
 
 
GISSI-P - Risikoreduktion
Figure 3: Use of highly purified omega-3 PUFAs in GISSI-Prevenzione was associated with significant reductions in the risk of a primary endpoint event (light bars) and reductions in the risk of several forms of cause-specific mortality (dark bars). Vitamin E alone had no significant effect on either primary outcome and the combination of highly purified omega-3 PUFAs plus vitamin E was not different from highly purified omega-3 PUFAs alone. Risk reductions derived from 4-way analysis; data from [9]


Keywords: DiagrammEndpointEndpunktGISSI-P studyGISSI-P-Studieomega-3 fatty acidOmega-3-FettsäurePUFAPUFAreductionReduktionRisikoriskVitamin EVitamin E
 
 
GISSI-P-Studie - Plötzlicher Herztod
Figure 4: There was evidence for a significant reduction in sudden death with highly purified omega-3 PUFAs in the GISSI-Prevenzione study after 4 months of treatment. Most of the early reduction in total mortality (p = 0.037 at 3 months) was attributable to the reduction in sudden death; modified from [9] (Calculated adjusting for treatment interaction and major confounding variables)


Keywords: DiagrammGISSI-P studyGISSI-P-Studieomega-3 fatty acidOmega-3-Fettsäureplötzlicher HerztodPUFAPUFAsudden death
 
 
Omega-3-Fettsäuren - Arrhythmien
Figure 5: Highly purified omega-3 PUFAs occupy a unique niche among post-MI medications, being the only therapy to target directly the electrical instability of the myocardium


Keywords: AntiarrhythmicsAntiarrhythmikumarrhythmiaArrhythmiemyocardiumMyokardomega-3 fatty acidOmega-3-FettsäurePUFAPUFASchema
 
 
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung